Carotuximab
Showing 1 - 9 of 9
Castration-resistant Prostate Cancer Trial in Los Angeles (Apalutamide, Carotuximab)
Not yet recruiting
- Castration-resistant Prostate Cancer
- Apalutamide
- Carotuximab
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Sep 6, 2022
Non Small Cell Lung Cancer, Lung Cancer Trial in Los Angeles (Osimertinib, Carotuximab)
Recruiting
- Non Small Cell Lung Cancer
- Lung Cancer
- Osimertinib
- Carotuximab
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Dec 20, 2022
NSCLC Trial in Birmingham, Tampa (Carotuximab (TRC105), OPDIVO)
Completed
- Carcinoma, Non-Small-Cell Lung
- Carotuximab (TRC105)
- OPDIVO
-
Birmingham, Alabama
- +1 more
Jun 11, 2020
Prostate Cancer Trial in Los Angeles (TRC105, Abiraterone, Enzalutamide)
Completed
- Prostate Cancer
- TRC105
- +2 more
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Dec 4, 2020
Advanced Soft Tissue Sarcoma Trial in United States (TRC105 and Pazopanib)
Completed
- Advanced Soft Tissue Sarcoma
- TRC105 and Pazopanib
-
Birmingham, Alabama
- +8 more
May 11, 2020
Hepatocellular Carcinoma Trial in Birmingham, Cleveland, Houston (Carotuximab (TRC105), Sorafenib)
Completed
- Hepatocellular Carcinoma
- Carotuximab (TRC105)
- Sorafenib
-
Birmingham, Alabama
- +2 more
Jul 2, 2020
Glioblastoma, Glioblastoma Multiforme Trial in Cincinnati, Cleveland, Columbus (TRC105, Bevacizumab)
Completed
- Glioblastoma
- Glioblastoma Multiforme
-
Cincinnati, Ohio
- +3 more
May 21, 2019
Metastatic Breast Cancer Trial in Birmingham, Buffalo (TRC105, Capecitabine)
Completed
- Metastatic Breast Cancer
-
Birmingham, Alabama
- +1 more
Feb 28, 2019